153. 難治頻回部分発作重積型急性脳炎 Disease details / Clinical trials / Drug dev / DR info /

臨床試験数 : 3 / 薬物数 : 3 - (DrugBank : 2) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 22

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Anakinra
   Beijing Childrens Hospital,Capital Medical University
      2026   -   ChiCTR2600126257   China
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States
Standard medical treatment
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States
Tocilizumab
   Beijing Childrens Hospital,Capital Medical University
      2026   -   ChiCTR2600126257   China
   Peking University First Hospital
      2024   Phase 4   ChiCTR2400085185   China
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States